Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free radical generation pathways refer to the diverse biochemical routes through which reactive oxygen species (ROS) and reactive nitrogen species (RNS) are produced within biological systems. These pathways include mitochondrial electron transport chain leakage, the activity of specialized enzymes such as NADPH oxidases (NOX), xanthine oxidase, and myeloperoxidase, as well as non-enzymatic processes like the Fenton and Haber-Weiss reactions (Lobo et al., 2010, Pharmacognosy Review). Under physiological conditions, these pathways are vital for cellular signaling, gene expression regulation, and the immune system's oxidative burst used to eliminate pathogens (Phaniendra et al., 2015, Indian Journal of Clinical Biochemistry). However, the dysregulation of these pathways leads to oxidative stress, which is implicated in the pathogenesis of cancer, neurodegenerative disorders like Alzheimer's, and cardiovascular diseases (Sies, 2017, Redox Biology). Pharmacological intervention typically targets specific enzymes within these pathways or employs antioxidant compounds to scavenge excess radicals, although broad-spectrum antioxidant therapy has faced challenges in clinical efficacy due to the disruption of essential redox signaling (Halliwell, 2011, British Journal of Pharmacology). Because this entry describes a broad set of biological processes rather than a single molecular target, it is classified as a pathway rather than a specific therapeutic receptor or enzyme.
Inhibition of radical-producing enzymes (e.g., xanthine oxidase, NADPH oxidase), scavenging of reactive species, and chelation of catalytic metal ions to prevent the Fenton reaction.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free radical generation pathways.